Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) dropped 12.3% during trading on Monday . The stock traded as low as GBX 3.19 and last traded at GBX 3.19. Approximately 1,175,647 shares were traded during trading, a decline of 6% from the average daily volume of 1,247,026 shares. The stock had previously closed at GBX 3.63.
Cizzle Biotechnology Stock Down 12.9%
The stock has a market capitalization of £10.70 million, a P/E ratio of -15.88 and a beta of 0.07. The stock has a 50 day simple moving average of GBX 2.34 and a two-hundred day simple moving average of GBX 1.84.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported GBX (0.17) EPS for the quarter.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Featured Stories
- Five stocks we like better than Cizzle Biotechnology
- Vertical Aerospace: Pre-Flight Checks Point to a Breakout
- Palo Alto Networks Up 70%: Can the Rally Last Into June?
- Block’s Pivot to Profits and AI Is Turning Heads
- HIVE Weaponizes Power for an AI Pivot
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
